Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grubbs

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Metabolites|July 25, 2019
Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary TumorsZhijun Cao, Mark Steven Miller, Ronald A Lubet, et al.
Molecular Cancer Therapeutics|May 2, 2006
Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamideYian Wang, Ruisheng Yao, Anna Maciag, et al.
Cancer Research|August 1, 1979
Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the ratP J Becci, H J Thompson, C J Grubbs, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamineRuisheng Yao, William J Lemon, Yian Wang, et al.
Oncology Reports|July 20, 2019
Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancersRobert H Shoemaker, Jennifer T Fox, Margaret M Juliana, et al.
Anticancer Research|March 1, 1985
Effect of long-term administration of retinoids on rats exposed transplacentally to ethylnitrosoureaC J Grubbs, D L Hill, D R Farnell, et al.
Oncology Reports|October 27, 2018
[Corrigendum] Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer modelsRonald A Lubet, Vernon E Steele, M M Juliana, et al.
Plos One|May 24, 2013
Diffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat modelGuihua Zhai, Clinton J Grubbs, Cecil R Stockard, et al.
Oncology Reports|March 23, 2018
Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer modelsRonald A Lubet, Vernon E Steele, M M Juliana, et al.
International Journal of Cancer|July 3, 1997
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer modelR A Lubet, V E Steele, I Eto, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Metabolites|July 25, 2019
Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary TumorsZhijun Cao, Mark Steven Miller, Ronald A Lubet, et al.
Molecular Cancer Therapeutics|May 2, 2006
Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamideYian Wang, Ruisheng Yao, Anna Maciag, et al.
Cancer Research|August 1, 1979
Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the ratP J Becci, H J Thompson, C J Grubbs, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamineRuisheng Yao, William J Lemon, Yian Wang, et al.
Oncology Reports|July 20, 2019
Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancersRobert H Shoemaker, Jennifer T Fox, Margaret M Juliana, et al.
Anticancer Research|March 1, 1985
Effect of long-term administration of retinoids on rats exposed transplacentally to ethylnitrosoureaC J Grubbs, D L Hill, D R Farnell, et al.
Oncology Reports|October 27, 2018
[Corrigendum] Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer modelsRonald A Lubet, Vernon E Steele, M M Juliana, et al.
Plos One|May 24, 2013
Diffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat modelGuihua Zhai, Clinton J Grubbs, Cecil R Stockard, et al.
Oncology Reports|March 23, 2018
Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer modelsRonald A Lubet, Vernon E Steele, M M Juliana, et al.
International Journal of Cancer|July 3, 1997
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer modelR A Lubet, V E Steele, I Eto, et al.
Pageof 16